Wave Life Sciences is trading at $5.93 (-5.04%) today as investors focus on the upcoming July 14 Singapore court hearing regarding its redomiciliation plan.
- The company noted that written submissions and affidavits tied to the Scheme of Arrangement were due by July 10, keeping the legal proceedings in focus for shareholders.
- The stock's decline also reflects broader biotech sector weakness, as the industry faces pressure from profit-taking and a general market risk-off sentiment.